Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohanad Mossalam

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Pharmaceutics|September 11, 2012
Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinibJonathan E Constance, David W Woessner, Karina J Matissek, et al.
Molecular Pharmaceutics|August 23, 2013
A chimeric p53 evades mutant p53 transdominant inhibition in cancer cellsAbood Okal, Mohanad Mossalam, Karina J Matissek, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Pharmaceutics|September 11, 2012
Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinibJonathan E Constance, David W Woessner, Karina J Matissek, et al.
Molecular Pharmaceutics|August 23, 2013
A chimeric p53 evades mutant p53 transdominant inhibition in cancer cellsAbood Okal, Mohanad Mossalam, Karina J Matissek, et al.
Pageof 2